MIM
ABMD

MetLife Investment Management’s Abiomed Inc ABMD Stock Holding History

MetLife Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,786
Closed -$3.39M – 2860
2022
Q3 		$3.39M Sell
13,786
-183
-1% -$49.4K 0.03% 625
2022
Q2 		$3.46M Sell
13,969
-258
-2% -$69.6K 0.03% 645
2022
Q1 		$4.71M Buy
14,227
+4,289
+43% +$1.32M 0.03% 571
2021
Q4 		$3.57M Sell
9,938
-165
-2% -$55.7K 0.03% 581
2021
Q3 		$3.29M Sell
10,103
-252
-2% -$85.4K 0.03% 585
2021
Q2 		$3.23M Sell
10,355
-277
-3% -$85K 0.03% 627
2021
Q1 		$3.39M Sell
10,632
-196
-2% -$62.7K 0.03% 599
2020
Q4 		$3.51M Sell
10,828
-445
-4% -$123K 0.03% 539
2020
Q3 		$3.12M Sell
11,273
-386
-3% -$111K 0.03% 518
2020
Q2 		$2.82M Buy
11,659
+20
+0.2% +$4.02K 0.03% 565
2020
Q1 		$1.69M Sell
11,639
-356
-3% -$59.1K 0.02% 673
2019
Q4 		$2.05M Sell
11,995
-354
-3% -$65.6K 0.02% 804
2019
Q3 		$2.2M Sell
12,349
-89
-0.7% -$19.2K 0.02% 743
2019
Q2 		$3.24M Sell
12,438
-376
-3% -$99.8K 0.03% 573
2019
Q1 		$3.66M Sell
12,814
-64
-0.5% -$21.3K 0.04% 507
2018
Q4 		$4.19M Sell
12,878
-174
-1% -$60.4K 0.05% 355
2018
Q3 		$5.87M Buy
13,052
+613
+5% +$242K 0.06% 301
2018
Q2 		$5.09M Sell
12,439
-13,812
-53% -$5M 0.06% 301
2018
Q1 		$7.64M Sell
26,251
-326
-1% -$82.6K 0.09% 204
2017
Q4 		$4.98M Buy
+26,577
New +$4.96M 0.06% 329

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MetLife Investment Management's ABMD Position: Q4 2022 in Review

MetLife Investment Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 13,786 shares — an estimated $3.39M sold.

MetLife Investment Management first reported a position in ABMD in Q4 2017 and held it in 20 quarters. The position peaked at $7.64M in Q1 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • MetLife Investment Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • MetLife Investment Management sold 13,786 Abiomed Inc shares in Q4 2022, an estimated $3.39M.
  • MetLife Investment Management first reported a position in Abiomed Inc in Q4 2017 and held it in 20 quarters.
  • MetLife Investment Management's Abiomed Inc position peaked at $7.64M in Q1 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.